Hypha is a privately held pharmaceutical discovery company uniquely placed to discover novel drug-leads from a collection of 2,500 highly diverse mushroom fungi (the basidiomycetes), much of it from tropical rainforest. Hypha has internal research programmes targeted for antibiotic and anticancer compound discovery. Hypha also provides contract services to pharmaceutical and biotechnology companies, for compound purification and identification (e.g. manufacturing impurities, natural products from various sources), and biological assays (anticancer, antibacterial and antifungal).